Who invested in 4D Molecular Therapeutics

3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$307Mraised across 3 rounds since 2015, from 3 sources

$7.0MVenture$100MRound$200MDebt

Latest round: Debt, $200MJun 2026
Step-upi: 2×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201520172019202120232025

$7.0MVenture$100MRound$200MDebt

First round: Venture, $7.0M
Biggest round: $200M
Usual gap between rounds: 10.3 years

The rounds

Jun 2026
Debt$200M1 new3 returning
Source recorded
Nov 2025
Round$100M3 new
Source recorded
Aug 2015
Venture$7.0M
No investor was named in the report.
From a historical funding recordSEC filing: $7.0M sold, first sale Aug 2015

Founders and team

From 4D Molecular Therapeutics's own website and the SEC filings it signed: 1 founder, 9 on the team.

Theresa JankeChief of Staff, Co-FounderNamed on its 2018 Form D

Chris SimmsChief Commercial & Business Officer
Kim MaplestoneChief Clinical Operations Officer
Kristian HumerChief Financial Officer
Glenn P. SblendorioBoard Member
Nancy Miller-RichBoard Member
David KirnExecutive Officer, Directori
David SchafferExecutive Officer, Directori
Leisa JohnsonExecutive Officeri
Peter FrancisExecutive Officeri

On the board, as filediCharles TheuerHoyoung HuhMargi McLaughlinTony Yao

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2015Round2025Debt2026

Perceptive Advisors

Janus Henderson Investors

Casdin Capital

Hercules Capital

Everyone who backed them

Perceptive AdvisorsAsset manager2rounds

Janus Henderson InvestorsPrivate equity2rounds

Casdin CapitalVC firm2rounds

Hercules CapitalVenture debt1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list 4D Molecular Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.